Jason Banks, MD
Neurological Surgery · Huntsville, ALNPI 1275534539
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $57,408 of the $64,750 with a category attached, or 88.7%. North Alabama Surgical Services, LLC accounts for 88.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $58,309 and has fallen 91.1% since, to $5,189 in 2025. Among neurological surgery clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $1904.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- North Alabama Surgical Services, LLC$57K
- Curiteva, Inc.$7K
- Si-bone, Inc.$198
- Providence Medical Technology, Inc.$188
- AbbVie$68
- Spinal Elements, Inc.$38
- plus $188 from 8 others
What the payments were for
- Royalty or licence$5,0748%
- Food & beverage$2,2674%
- Ownership interest$57,40889%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| North Alabama Surgical Services, LLC | 1 | $57,408 |
| Curiteva, Inc. | 5 | $6,662 |
| Si-bone, Inc. | 9 | $198 |
| Providence Medical Technology, Inc. | 5 | $188 |
| AbbVie | 4 | $68 |
| Spinal Elements, Inc. | 1 | $38 |
| Abbott | 2 | $34 |
| Arteriocyte Medical Systems, Inc. | 1 | $32 |
| Prime Surgical, LLC | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $25 |
| Stryker | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Zimmer Biomet | 1 | $15 |
| Wenzel Spine, Inc. | 1 | $14 |
How this compares
$64,750 in reported general payments places this provider in the 90th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $823 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 97 | $701 |
| Methocarbamol | 92 | $678 |
| Methylprednisolone | 72 | $608 |
| Gabapentin | 29 | $473 |
| Tizanidine Hcl | 18 | $126 |
| Tramadol Hcl | 31 | $99 |
| Cyclobenzaprine Hcl | 16 | $72 |
| Diazepam | 19 | $32 |
| Lorazepam | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Huntsville
- John JohnsonHuntsville$250K
- Cheng TaoHuntsville$236K
- Joel PickettHuntsville$72K
- Sanat DixitHuntsville$5K
- Rhett MurrayHuntsville$4K
- Moneeb EhteshamHuntsville$3K
- Thomas OstergardHuntsville$2K
- Mark HadleyBirmingham$104K
- Andrew ErwoodBirmingham$85K
- Marshall HollandBirmingham$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.